Back

The role of biomarkers, sleep apnea and echocardiography as predictors of atrial fibrillation in a pacemaker population.

16 April 2023 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: ePoster session 40 Diagnostic Methods EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Ana Isabel Santos Sanchez

University Hospital of Burgos, Burgos (Spain)

9 More presentations in this session

Presentation thumbnail
Disagreement of ESC guidelines from 2016 and 2021 and HFA-PEFF and H2 FPEF scores in diagnosis of heart failure with preserved ejection fraction in atrial fibrillation patients
Mrs S. Hubers (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Arrhythmic substrate in pulmonary vein isolation reprocedures in the era of the close protocol.
Doctor C. Gonzalez De La Portilla-Concha (Badajoz, ES)
Abstract Slides
Presentation thumbnail
Minimizing radiation in cryoballon-based ablation of the pulmonary veins through a novel high-resolution wide-band dielectric imaging system
Doctor V. Buia (Fuerth, DE)
Abstract Slides
Presentation thumbnail
Heterogeneity in voltage and activation time in the left atrium of atrial fibrillation patients undergoing pulmonary vein isolation
Ms I. Meijer (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Comparison of pulsed field ablation and cryoballoon ablation in atrial fibrillation
Mr J. Schipper (Cologne, DE)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 40

The Event

Event poster

EHRA 2023

16 April - 18 April 2023
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources